Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection
- PMID: 38172152
- PMCID: PMC10764833
- DOI: 10.1038/s41598-023-50335-6
Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection
Abstract
SARS-CoV-2 reinfections have been frequent, even among those vaccinated. The aim of this study is to know if hybrid immunity (infection + vaccination) is affected by the moment of vaccination and number of doses received. We conducted a retrospective study in 746 patients with a history of COVID-19 reinfection and recovered the dates of infection and reinfection and vaccination status (date and number of doses). To assess differences in the time to reinfection(tRI) between unvaccinated, vaccinated before 6 months, and later; and comparing one, two or three doses (incomplete, complete and booster regime) we performed the log-rank test of the cumulative incidence calculated as 1 minus the Kaplan-Meier estimator. Also, an adjusted Cox-regression was performed to evaluate the risk of reinfection in all groups. The tRI was significantly higher in those vaccinated vs. non-vaccinated (p < 0.001). However, an early incomplete regime protects similar time than not receiving a vaccine. Vaccination before 6 months after infection showed a lower tRI compared to those vaccinated later with the same regime (adj-p < 0.001). Actually, early vaccination with complete and booster regimes provided lower length of protection compared to vaccinating later with incomplete and complete regime, respectively. Vaccination with complete and booster regimes significantly increases the tRI (adj-p < 0.001). Vaccination increases the time it takes for a person to become reinfected with SARS-CoV-2. Increasing the time from infection to vaccination increases the time in which a person could be reinfected and reduces the risk of reinfection, especially in complete and booster regimes. Those results emphasize the role of vaccines and boosters during the pandemic and can guide strategies on future vaccination policy.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico.Front Public Health. 2023 Apr 4;11:1146059. doi: 10.3389/fpubh.2023.1146059. eCollection 2023. Front Public Health. 2023. PMID: 37081954 Free PMC article.
-
SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.Viruses. 2023 Jul 14;15(7):1551. doi: 10.3390/v15071551. Viruses. 2023. PMID: 37515237 Free PMC article.
-
Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.Lancet Infect Dis. 2022 Jun;22(6):781-790. doi: 10.1016/S1473-3099(22)00143-8. Epub 2022 Apr 1. Lancet Infect Dis. 2022. PMID: 35366962 Free PMC article.
-
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.BMC Infect Dis. 2023 Jun 26;23(1):432. doi: 10.1186/s12879-023-08328-3. BMC Infect Dis. 2023. PMID: 37365490 Free PMC article.
-
Breakthrough SARS-CoV-2 infections after vaccination: a critical review.Hum Vaccin Immunother. 2022 Nov 30;18(5):2051412. doi: 10.1080/21645515.2022.2051412. Epub 2022 Mar 18. Hum Vaccin Immunother. 2022. PMID: 35302905 Free PMC article. Review.
Cited by
-
Identifying risk factors and predicting long COVID in a Spanish cohort.Sci Rep. 2025 Mar 28;15(1):10758. doi: 10.1038/s41598-025-94765-w. Sci Rep. 2025. PMID: 40155409 Free PMC article.
-
Impact of COVID-19 on live birth and perinatal outcomes following subsequent frozen-thawed embryo transfer.J Assist Reprod Genet. 2025 Aug 15. doi: 10.1007/s10815-025-03573-8. Online ahead of print. J Assist Reprod Genet. 2025. PMID: 40815354
-
Determinants of COVID-19 vaccine uptake among persons with disabilities in three selected districts of Zambia.PLOS Glob Public Health. 2025 Jul 7;5(7):e0003868. doi: 10.1371/journal.pgph.0003868. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 40623023 Free PMC article.
-
Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.Front Public Health. 2024 Aug 26;12:1457266. doi: 10.3389/fpubh.2024.1457266. eCollection 2024. Front Public Health. 2024. PMID: 39253287 Free PMC article.
References
-
- World Health Organisation (WHO). WHO Coronavirus (COVID-19) Dashboard [Internet] (2023, accessed 10 May 2023). https://covid19.who.int/.
-
- Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: A pooled analysis of four randomised trials. The Lancet. 2021;397:881–891. doi: 10.1016/S0140-6736(21)00432-3. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous